Current HIV/AIDS Reports

, Volume 11, Issue 1, pp 1–10

Are Infants Unique in Their Ability to be “Functionally Cured” of HIV-1?

HIV Pathogenesis and Treatment (AL Landay, Section Editor)

DOI: 10.1007/s11904-013-0189-1

Cite this article as:
Tobin, N.H. & Aldrovandi, G.M. Curr HIV/AIDS Rep (2014) 11: 1. doi:10.1007/s11904-013-0189-1


The recent report of an infant that appears to have achieved a “functional cure” of HIV-1 following receipt of antiretroviral therapy (ART) within 30 hours of birth raises many questions: was the child infected? Was this result due to unique features of this particular infant’s immune system, the immune system of infants or the very early initiation of effective ART? In this manuscript, we discuss the pathogenesis of HIV-1 in infants, highlighting the unique features of infant immune development and how these may inform efforts to cure HIV infection. We will also compare the path to infant “cure” to cures in adults.


HIV Mother-to-child transmission (MTCT) Neonate Infant Pathogenesis Cure CD4+ T cells CD8+ T cells Central memory T cells (TCMEffector memory T cells (TEMReservoir Immune quiescence Immune tolerance Microbial translocation Functional cure HIV-1 Antiretroviral therapy (ART) HIV pathogenesis 

Copyright information

© Springer Science+Business Media New York 2014

Authors and Affiliations

  1. 1.Department of PediatricsChildren’s Hospital Los AngelesLos AngelesUSA
  2. 2.Department of Pediatrics, Children’s Hospital Los AngelesThe Saban Research Institute, University of Southern CaliforniaLos AngelesUSA

Personalised recommendations